Related references
Note: Only part of the references are listed.Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade
Frederick J. Kohlhapp et al.
CANCER DISCOVERY (2021)
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
Yael C. Cohen et al.
NATURE MEDICINE (2021)
Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemia
Benjamin Demaree et al.
NATURE COMMUNICATIONS (2021)
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Benedith Oben et al.
NATURE COMMUNICATIONS (2021)
Co-evolution of tumor and immune cells during progression of multiple myeloma
Ruiyang Liu et al.
NATURE COMMUNICATIONS (2021)
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape
Madelon M. E. de Jong et al.
NATURE IMMUNOLOGY (2021)
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
Juan-Jose Garces et al.
LEUKEMIA (2020)
Structural variation in the sequencing era
Steve S. Ho et al.
NATURE REVIEWS GENETICS (2020)
Dissecting racial disparities in multiple myeloma
Catherine R. Marinac et al.
BLOOD CANCER JOURNAL (2020)
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression
Mark Bustoros et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Ahmet Acar et al.
NATURE COMMUNICATIONS (2020)
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Juan-Jose Garces et al.
LEUKEMIA (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
Kiyomi Morita et al.
NATURE COMMUNICATIONS (2020)
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Maria-Victoria Mateos et al.
BLOOD CANCER JOURNAL (2020)
A molecular cell atlas of the human lung from single-cell RNA sequencing
Kyle J. Travaglini et al.
NATURE (2020)
Single-cell mutation analysis of clonal evolution in myeloid malignancies
Linde A. Miles et al.
NATURE (2020)
Deep learning of circulating tumour cells
Leonie L. Zeune et al.
NATURE MACHINE INTELLIGENCE (2020)
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Oksana Zavidij et al.
NATURE CANCER (2020)
Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
Ankit K. Dutta et al.
LEUKEMIA (2019)
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients
John R. Jones et al.
HAEMATOLOGICA (2019)
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma
Leo Rasche et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The multiple myeloma drug market
Paul Wilcock et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells
Weng Hua Khoo et al.
BLOOD (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Benjamin G. Barwick et al.
NATURE COMMUNICATIONS (2019)
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma
Benjamin G. Barwick et al.
FRONTIERS IN IMMUNOLOGY (2019)
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
Francesco Maura et al.
NATURE COMMUNICATIONS (2019)
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy
Luzalba Sanoja-Flores et al.
BLOOD (2019)
Molecular signatures of multiple myeloma progression through single cell RNA-Seq
Jin Sung Jang et al.
BLOOD CANCER JOURNAL (2019)
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement
David Murray et al.
BLOOD CANCER JOURNAL (2019)
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A. Walker et al.
BLOOD (2018)
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
Phuc H. Hoang et al.
LEUKEMIA (2018)
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing
Guangwu Guo et al.
LEUKEMIA (2018)
Multiple myeloma clonal evolution in homogeneously treated patients
Jill Corre et al.
LEUKEMIA (2018)
The bone-marrow niche in MDS and MGUS: implications for AML and MM
Irene M. Ghobrial et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
S. Manier et al.
NATURE COMMUNICATIONS (2018)
Precision Prevention and Early Detection of Cancer: Fundamental Principles
Timothy R. Rebbeck et al.
CANCER DISCOVERY (2018)
Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Andrew J. Cowan et al.
JAMA ONCOLOGY (2018)
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
Aurore Perrot et al.
BLOOD (2018)
Cancer genetics, precision prevention and a call to action
Clare Turnbull et al.
NATURE GENETICS (2018)
Genomic patterns of progression in smoldering multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2018)
BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment
Patricia Gomez-Bougie et al.
BLOOD (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Guy Ledergor et al.
NATURE MEDICINE (2018)
Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders
Brad Foulk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
Aneta Mikulasova et al.
HAEMATOLOGICA (2017)
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
Miquel Granell et al.
HAEMATOLOGICA (2017)
The Human Cell Atlas: from vision to reality
Orit Rozenblatt-Rosen et al.
NATURE (2017)
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
L. Rasche et al.
NATURE COMMUNICATIONS (2017)
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
Olena Kis et al.
NATURE COMMUNICATIONS (2017)
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Yuji Mishima et al.
CELL REPORTS (2017)
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
Aneta Mikulasova et al.
HAEMATOLOGICA (2017)
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
Miquel Granell et al.
HAEMATOLOGICA (2017)
DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment
Duncan R. Hewett et al.
NEOPLASIA (2017)
Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding
Payam Shahi et al.
SCIENTIFIC REPORTS (2017)
Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma
Xiaoyan Feng et al.
CLINICAL CANCER RESEARCH (2017)
Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma
Ankit K. Dutta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis
Bruno Paiva et al.
BLOOD (2016)
BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics
C. Touzeau et al.
LEUKEMIA (2016)
Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2016)
MGUS to myeloma: a mysterious gammopathy of underexplored significance
Madhav V. Dhodapkar
BLOOD (2016)
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
Niels Weinhold et al.
BLOOD (2016)
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial
Maria-Victoria Mateos et al.
LANCET ONCOLOGY (2016)
Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
Rituparna Das et al.
NATURE MEDICINE (2016)
Single-cell genome sequencing: current state of the science
Charles Gawad et al.
NATURE REVIEWS GENETICS (2016)
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
Jens G. Lohr et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)
K. M. Kortuem et al.
ANNALS OF HEMATOLOGY (2015)
New criteria for response assessment: role of minimal residual disease in multiple myeloma
Bruno Paiva et al.
BLOOD (2015)
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
Brian A. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
Joaquin Martinez-Lopez et al.
BLOOD (2014)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
B. A. Walker et al.
LEUKEMIA (2014)
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
L. Melchor et al.
LEUKEMIA (2014)
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
W. I. Gonsalves et al.
LEUKEMIA (2014)
Serial exome analysis of disease progression in premalignant gammopathies
S. Zhao et al.
LEUKEMIA (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
Bruno Paiva et al.
BLOOD (2013)
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
G. Bianchi et al.
LEUKEMIA (2013)
Exome sequencing in tracking clonal evolution in multiple myeloma following therapy
N. Weston-Bell et al.
LEUKEMIA (2013)
Minor clone provides a reservoir for relapse in multiple myeloma
F. Magrangeas et al.
LEUKEMIA (2013)
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Maria-Victoria Mateos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting the BRAF V600E Mutation in Multiple Myeloma
Mindaugas Andrulis et al.
CANCER DISCOVERY (2013)
Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
Jan B. Egan et al.
BLOOD (2012)
Myeloma as a model for the process of metastasis: implications for therapy
Irene M. Ghobrial
BLOOD (2012)
Clonal competition with alternating dominance in multiple myeloma
Jonathan J. Keats et al.
BLOOD (2012)
Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites
A. J. Greenberg et al.
LEUKEMIA (2012)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
Guellue Goerguen et al.
BLOOD (2010)
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Marc H. G. P. Raaijmakers et al.
NATURE (2010)
A monoclonal gammopathy precedes multiple myeloma in most patients
Brendan M. Weiss et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Ernesto Perez-Persona et al.
BLOOD (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Macrofocal multiple myeloma in young patients: A distinct entity with favorable prognosis
Meletios Athanasios Dimopoulos et al.
LEUKEMIA & LYMPHOMA (2006)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma
GS Nowakowski et al.
BLOOD (2005)
Genomic abnormalities in monoclonal gammopathy of undetermined significance
R Fonseca et al.
BLOOD (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
